# Effects of Administration of Fostamatinib on Blood Concentrations of Pioglitazone in Healthy Subjects

> **NCT01309854** · PHASE1 · COMPLETED · sponsor: **AstraZeneca** · enrollment: 15 (estimated)

## Conditions studied

- Rheumatoid Arthritis
- Healthy Volunteers
- Pharmacokinetics
- Pioglitazone
- Drug-drug Interaction
- Amount of Pioglitazone in Blood

## Interventions

- **DRUG:** fostamatinib
- **DRUG:** pioglitazone

## Key facts

- **NCT ID:** NCT01309854
- **Lead sponsor:** AstraZeneca
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-03
- **Primary completion:** 2011-05
- **Final completion:** 2011-05
- **Target enrollment:** 15 (ESTIMATED)
- **Last updated:** 2011-07-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01309854

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01309854, "Effects of Administration of Fostamatinib on Blood Concentrations of Pioglitazone in Healthy Subjects". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT01309854. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*